Achieving and maintaining asthma control in inner-city children - 11/08/11
, Tricia Morphew, MS b, Mary E. Bollinger, DO c, Steve Samuelson, MPA d, Stanley Galant, MD e, Loran Clement, MD f, Karen O’Cull, RT g, Felita Jones, MPA b, Craig A. Jones, MD hAbstract |
Background |
Despite guidelines-defined care, inner-city children of low socioeconomic status have poor asthma control.
Objective |
This study evaluated time to achieve control, maintenance of control, and factors associated with well controlled asthma for pediatric patients receiving specialty-based asthma care in mobile asthma clinics designed to reduce barriers to delivering effective asthma care (the Breathmobile Program).
Methods |
Existing clinical data collected from January 1998 to June 2008 for 7822 pediatric patients with asthma (34,339 visits) enrolled in similarly structured mobile asthma programs across the United States evaluated the effect of asthma control on the reduction of asthma-related morbidity, time to achieve asthma control, maintenance of asthma control, and factors associated with well controlled asthma.
Results |
Comparison of pre and post year data for subjects enrolled in the program for at least 1 year revealed reductions in the percentage of patients reporting emergency department visits (mean, 66%), hospitalizations (mean, 84%), and missed school days ≥5/year (mean, 78%). Well controlled asthma was achieved by visit 3 for an estimated 80% of patients. Factors contributing to well controlled asthma include non-African American race, visit interval <90 days, and adherence to prescribed therapy.
Conclusion |
This study demonstrates the ability to achieve and maintain asthma control in high-risk populations in association with intensive, accessible, guidelines-defined care with close follow-up.
Le texte complet de cet article est disponible en PDF.Key words : Pediatric asthma, inner city, asthma control, asthma morbidity
Abbreviations used : BMI, ED, MC, NAEPP, NHLBI, OR, TC, WCA
Plan
| Support for analysis of data was provided by the Asthma and Allergy Foundation of America, California Chapter. |
|
| Disclosure of potential conflict of interest: C. A. Jones is on the Merck US Respiratory Advisory Board. The rest of the authors have declared that they have no conflict of interest. |
Vol 128 - N° 1
P. 56-63 - juillet 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
